Caritis, Steve N |
NCT03831113: Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy |
|
|
| Terminated | 2 | 13 | US | Magnitude Group, magnitude, Frequency Group, frequency | Steve N. Caritis, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Opiate Addiction, Pregnancy | 12/22 | 12/22 | | |
NCT02863601: Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics |
|
|
| Completed | N/A | 25 | US | | University of Pittsburgh | Opiate Addiction, Pregnancy | 05/22 | 05/22 | | |
| Terminated | N/A | 24 | US | 17-Hydroxyprogesterone Caproate 250 mg IM Dose, 17-OHPC, 17-Hydroxyprogesterone Caproate 275 mg SC Dose | Steve N. Caritis, MD, AMAG Pharmaceuticals, Inc. | Preterm Birth | 04/23 | 04/23 | | |
Venkataramanan, Raman |
NCT03831113: Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy |
|
|
| Terminated | 2 | 13 | US | Magnitude Group, magnitude, Frequency Group, frequency | Steve N. Caritis, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Opiate Addiction, Pregnancy | 12/22 | 12/22 | | |
Fischer, Dawn |
NCT03831113: Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy |
|
|
| Terminated | 2 | 13 | US | Magnitude Group, magnitude, Frequency Group, frequency | Steve N. Caritis, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Opiate Addiction, Pregnancy | 12/22 | 12/22 | | |
DeAngelis, Donna |
NCT03831113: Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy |
|
|
| Terminated | 2 | 13 | US | Magnitude Group, magnitude, Frequency Group, frequency | Steve N. Caritis, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Opiate Addiction, Pregnancy | 12/22 | 12/22 | | |